Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Adding a second method to PROTACs could improve cancer treatment.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Nanoparticle systems make cancer treatment less toxic.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Panitumumab can cause excessive ear hair growth.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.